Australia markets closed

Getein Biotech, Inc (603387.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
9.71-0.22 (-2.22%)
At close: 03:00PM CST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
244,259
279,772
498,910
398,990
304,733
Depreciation & amortisation
-
93,085
70,352
49,405
35,927
Change in working capital
-
-72,088
-120,223
-38,265
-175,062
Inventory
-
17,342
-52,247
-43,268
-40,263
Other working capital
125,621
75,093
265,513
252,768
71,936
Other non-cash items
-
14,395
4,969
22,413
21,442
Net cash provided by operating activities
-
333,221
482,958
432,365
185,469
Cash flows from investing activities
Investments in property, plant and equipment
-261,230
-258,128
-217,444
-179,597
-113,533
Acquisitions, net
-
-
-
-
-54,054
Purchases of investments
-528,574
-433,457
-1,026,556
-132,417
-120,796
Sales/maturities of investments
216,872
322,877
478,989
56,809
45,503
Other investing activities
-
-
-
-2,297
-113,533
Net cash used for investing activities
-560,844
-356,827
-760,440
-254,632
-238,714
Net change in cash
-312,033
-157,811
-304,164
147,784
140,716
Cash at beginning of period
732,977
640,987
945,151
797,367
656,650
Cash at end of period
406,905
483,176
640,987
945,151
797,367
Free cash flow
Operating cash flow
-
333,221
482,958
432,365
185,469
Capital expenditure
-261,230
-258,128
-217,444
-179,597
-113,533
Free cash flow
125,621
75,093
265,513
252,768
71,936